-

Exosome Diagnostics, Therapeutics and Research Tools Global Market Research 2024-2028: Commercial Opportunities and Trends, Patent Analysis and Sustainability Trends, Competitive Landscape - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Exosome Diagnostics, Therapeutics and Research Tools: Global Markets" report has been added to ResearchAndMarkets.com's offering.

The global market for exosome diagnostics, therapeutics and research tools is estimated to increase from $227.5 million in 2023 to reach $1.3 billion by 2028, at a compound annual growth rate (CAGR) of 42.2% from 2023 through 2028.

The global market for exosome diagnostics and therapeutics saw revenue data amounting to a significant figure in 2021-2022, with estimates for 2023 and forecasts for 2024 projecting robust growth. The market is expected to witness a strong compound annual growth rate (CAGR) through 2028. This analysis provides a comprehensive estimate of the current market size and revenue growth prospects, alongside a detailed market share analysis based on product, application, end user, and region.

Market Drivers, Opportunities, and Restraints

Key market drivers include the growing application of exosome diagnostics in personalized medicine and the rising prevalence of chronic diseases. Opportunities abound in the expanding research activities related to exosomes and their therapeutic potential. However, market growth is restrained by factors such as high costs associated with exosome isolation and the complexity of regulatory pathways. Macroeconomic variables also play a crucial role in shaping the market dynamics.

Emerging Technologies, Regulations, and R&D Efforts

The market is experiencing significant advancements in emerging technologies related to exosome diagnostics and therapeutics. There is a strong emphasis on regulatory frameworks and R&D efforts aimed at enhancing the efficacy and safety of exosome-based products. These developments are crucial in facilitating new commercial opportunities in diagnostics, therapeutics, and research tools markets.

Commercial Opportunities and Trends

New commercial opportunities are emerging in the diagnostics, therapeutics, and research tools markets. Trends such as the development of novel assay technologies and innovative products are driving market growth. The use of exosome proteins and nucleic acids as diagnostic biomarkers is gaining traction, particularly in microRNA, liquid biopsy, and stem cell research industries.

Patent Analysis and Sustainability Trends

Relevant patents in the U.S., Europe, and Japan are analyzed to provide insights into the technological advancements and intellectual property landscape in exosome diagnostics and therapeutics. Additionally, sustainability trends and ESG developments are reviewed, highlighting consumer attitudes, companies' ESG score rankings, and their sustainability practices.

Competitive Landscape

The competitive landscape is thoroughly analyzed, including companies' market shares, business segments, financials, and product portfolios. Recent mergers and acquisitions (M&A) activity and a venture funding outlook are also discussed, providing a clear picture of the industry's competitive dynamics. Company profiles of major players such as Bio-Techne, Exosomics S.p.A., and System Biosciences LLC are included to offer detailed insights into their strategies and market positioning.

Company Profiles

  • Acousort Ab
  • Aegle Therapeutics
  • Aethlon Medical Inc.
  • Aruna Bio Inc.
  • Bio-Techne
  • Capricor Therapeutics Inc.
  • Caris Life Sciences
  • Direct Biologics Llc
  • Exosomics Spa
  • Evox Therapeutics Ltd.
  • Kimera Labs
  • Lonza
  • Mir Scientific
  • Nano Med
  • Nanosomix
  • Rion
  • System Biosciences Llc

Key Topics Covered:

Chapter 1 Executive Summary

  • Market Outlook
  • Scope of Report
  • Market Summary

Chapter 2 Market Overview

  • Exosome Basics
  • Exosome Biogenesis and Processing
  • Exosome Function and Physiology
  • Intracellular Communication
  • Facilitation of the Immune Response
  • Tissue Regeneration
  • Bioinformatic Databases for Exosome Research and Product Development
  • ExoCarta
  • Vesiclepedia
  • EVpedia

Chapter 3 Market Dynamics

  • Overview
  • Market Drivers
  • Increasing Investment in Biomedical Research
  • Trend Towards Precision Medicine
  • Technological Advancements in Exosome Research Tools
  • Restraints
  • Evolving Regulatory Landscape
  • Lack of Well-Characterized Exosome Standards
  • Opportunities
  • Growing Popularity in Liquid Biopsy
  • Benefits Over Stem Cell Therapy
  • Challenges
  • Funding Issues

Chapter 4 Regulatory Landscape

  • U.S.
  • Exosome Therapeutics
  • Exosome Clinical Assays Development and Marketing

Chapter 5 Emerging Technologies and Developments

  • Emerging Technologies
  • Engineered Exosomes
  • Microfluidic Technology
  • Exosome Research Services
  • Exosome Based Liquid Biopsy Tests
  • Clinical Trial Analysis
  • Overview
  • By Phases
  • By Funder Type
  • By Disease Type
  • By Country
  • Pipeline Analysis

Chapter 6 Market Segmentation Analysis

  • Segmental Breakdown
  • Market Analysis by Application Type
  • Diagnostics and Monitoring
  • Evaluation of the Diagnostics and Monitoring Market
  • Cancer
  • CNS Disorders and Neurodegeneration Diseases
  • Organ Transplantation
  • Cardiovascular Diseases
  • Others
  • Diagnostics and Monitoring Market Revenue
  • Exosome Therapeutics
  • Potential Therapeutic Applications
  • Evaluation of the Current and Potential Therapeutics Market
  • Key Target Indications
  • Research Tools and Regents
  • Research Tools and Reagents Market Revenue
  • Geographic Breakdown
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World (RoW)

Chapter 7 Competitive Intelligence

  • Overview
  • Exosome-Based Clinical Diagnostics Market
  • Market Participants in the Exosome-Based Clinical Diagnostics Market
  • Exosome-Based Therapeutics Market
  • Market Participants in the Exosome-Based Therapeutics Market
  • Exosome Research Tools and Reagents Market
  • Market Participants in the Exosome Research Tools and Reagents Market
  • Key Strategies
  • Opportunities and Challenges in the Exosome Market

Chapter 8 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/goynks

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Growth Opportunities in Digital Logistics: Set to Exceed a Market Valuation of $85 Billion by 2030, Booming at 25% CAGR - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Digital Logistics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Digital Logistics Market will grow from USD 22.30 Billion in 2024 to USD 85.07 Billion by 2030 at a 25% CAGR. Main drivers include the exponential growth of e-commerce, which demands faster and more transparent delivery, and the increasing need for real-time supply chain oversight. Key Market Drivers...

The Global T-cell Therapy Market 2025-2030 by Therapy Type, Indication and Region - Shift Towards Allogeneic Platforms to Boost Market Accessibility - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "T-cell Therapy Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global T-cell Therapy Market, valued at USD 2.92 Billion in 2024, is projected to experience a CAGR of 9.90% to reach USD 5.14 Billion by 2030. The market's expansion is significantly propelled by the increasing global prevalence of various cancers, continuous technological advancements in genetic engineering...

Molecular Cytogenetics Market Intelligence Report (2020-2030) Featuring Key Players Danaher, MetaSystems, Agilent Technologies, Abbott Labs, Bio-Rad Labs and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Molecular Cytogenetics Market - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030" has been added to ResearchAndMarkets.com's offering. The Global Molecular Cytogenetics Market, valued at USD 2.24 Billion in 2024, is projected to experience a CAGR of 8.33% to reach USD 3.62 Billion by 2030. This market's expansion is fundamentally driven by the increasing global prevalence of genetic conditions and oncological diseases, necessitating preci...
Back to Newsroom